BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8968403)

  • 1. The staurosporine producing strain Streptomyces longisporoflavus produces metabolites related to K-252a. Proposal for biosynthetic intermediates of K-252a.
    Cai Y; Fredenhagen A; Hug P; Peter HH
    J Antibiot (Tokyo); 1996 Oct; 49(10):1060-2. PubMed ID: 8968403
    [No Abstract]   [Full Text] [Related]  

  • 2. Production of the staurosporine aglycon K-252c with a blocked mutant of the staurosporine producer strain Streptomyces longisporoflavus and by biotransformation of staurosporine with Streptomyces mediocidicus ATCC 13279.
    Goeke K; Hoehn P; Ghisalba O
    J Antibiot (Tokyo); 1995 May; 48(5):428-30. PubMed ID: 7797446
    [No Abstract]   [Full Text] [Related]  

  • 3. Further minor metabolites of staurosporine produced by a Streptomyces longisporoflavus strain.
    Cai Y; Fredenhagen A; Hug P; Meyer T; Peter HH
    J Antibiot (Tokyo); 1996 Jun; 49(6):519-26. PubMed ID: 8698633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nitro analogue of staurosporine and other minor metabolites produced by a Streptomyces longisporoflavus strain.
    Cai Y; Fredenhagen A; Hug P; Peter HH
    J Antibiot (Tokyo); 1995 Feb; 48(2):143-8. PubMed ID: 7706124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activities of indolocarbazole and bis-indole protein kinase C inhibitors.
    Sancelme M; Fabre S; Prudhomme M
    J Antibiot (Tokyo); 1994 Jul; 47(7):792-8. PubMed ID: 8071125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning, sequence analysis and functional characterization of the gene cluster for biosynthesis of K-252a and its analogs.
    Chiu HT; Chen YL; Chen CY; Jin C; Lee MN; Lin YC
    Mol Biosyst; 2009 Oct; 5(10):1180-91. PubMed ID: 19756308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membranes of human neuroblastoma SH-SY5Y cells contain specific binding sites for [3H]K-252A.
    Knight E; Connors TJ; Hudkins R; Maroney AC; Neff N
    Biochem Biophys Res Commun; 1995 Jun; 211(2):511-8. PubMed ID: 7794263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.
    White JR; Zembryki D; Hanna N; Mong S
    Biochem Pharmacol; 1990 Aug; 40(3):447-56. PubMed ID: 1696482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of staurosporine, K 252a and other structurally related protein kinase inhibitors on shape and locomotion of Walker carcinosarcoma cells.
    Zimmermann A; Keller H
    Br J Cancer; 1992 Dec; 66(6):1077-82. PubMed ID: 1457347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic organization of the biosynthetic gene cluster for the indolocarbazole K-252a in Nonomuraea longicatena JCM 11136.
    Kim SY; Park JS; Chae CS; Hyun CG; Choi BW; Shin J; Oh KB
    Appl Microbiol Biotechnol; 2007 Jul; 75(5):1119-26. PubMed ID: 17396254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of protein kinase inhibitors on in vitro protein phosphorylation and cellular differentiation of Streptomyces griseus.
    Hong SK; Matsumoto A; Horinouchi S; Beppu T
    Mol Gen Genet; 1993 Jan; 236(2-3):347-54. PubMed ID: 8437579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further metabolic studies of indole and sugar derivatives using the staurosporine producer Streptomyces staurosporeus.
    Yang SW; Cordell GA
    J Nat Prod; 1997 Mar; 60(3):230-5. PubMed ID: 9090865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new inhibitor of protein kinase C, RK-1409 (7-oxostaurosporine). I. Taxonomy and biological activity.
    Osada H; Koshino H; Kudo T; Onose R; Isono K
    J Antibiot (Tokyo); 1992 Feb; 45(2):189-94. PubMed ID: 1556009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structures of the novel protein kinase C inhibitors K-252a, b, c and d.
    Yasuzawa T; Iida T; Yoshida M; Hirayama N; Takahashi M; Shirahata K; Sano H
    J Antibiot (Tokyo); 1986 Aug; 39(8):1072-8. PubMed ID: 3759659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the protein kinase inhibitors, staurosporine and K-252a, on PGI2 production by rat liver cells (the C-9 cell line).
    Levine L
    Prostaglandins; 1990 Sep; 40(3):259-69. PubMed ID: 2247616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial biosynthesis of antitumor indolocarbazole compounds.
    Sánchez C; Zhu L; Braña AF; Salas AP; Rohr J; Méndez C; Salas JA
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):461-6. PubMed ID: 15625109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3'-Demethoxy-3'-hydroxystaurosporine, a novel staurosporine analogue produced by a blocked mutant.
    Hoehn P; Ghisalba O; Moerker T; Peter HH
    J Antibiot (Tokyo); 1995 Apr; 48(4):300-5. PubMed ID: 7775266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the antiviral mechanisms of protein kinase inhibitors K-252a and KT5926 against the replication of vesicular stomatitis virus.
    Kim YS; Kawai A
    Biol Pharm Bull; 1998 May; 21(5):498-505. PubMed ID: 9635507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of specific binding sites for [3H]-staurosporine on various protein kinases.
    Herbert JM; Seban E; Maffrand JP
    Biochem Biophys Res Commun; 1990 Aug; 171(1):189-95. PubMed ID: 2393390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of potent and selective kinase inhibitors by combinatorial biosynthesis of glycosylated indolocarbazoles.
    Sánchez C; Salas AP; Braña AF; Palomino M; Pineda-Lucena A; Carbajo RJ; Méndez C; Moris F; Salas JA
    Chem Commun (Camb); 2009 Jul; (27):4118-20. PubMed ID: 19568652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.